IL1B and inflammatory bowel disease: IL1B. IL1B is of particular interest because of its implication in IBD pathology (Aschenbrenner et al. 2021) and because LPS-inducible expression is at least ten-fold lower in MDM compared to freshly-isolated monocytes (Baillie et al. 2017).